Division of Infectious Diseases

genetic sequence
August 6, 2015

Genotyping project to be an ‘engine of discovery’

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known.

By Bill Snyder
July 9, 2015

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

By Bill Snyder
AIDS ribbon on the globe
June 25, 2015

VUMC, Meharry and State Health Department receive NIH grant to establish AIDS research center

Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health.

By Bill Snyder
November 24, 2014

Twelve Vanderbilt faculty elected AAAS fellows

Twelve members of Vanderbilt’s faculty have been elected fellows of the American Association for the Advancement of Science for their “scientifically or socially distinguished efforts to advance science or its applications.”

By Bill Snyder
November 21, 2014

Host sequesters zinc to control stomach bug

Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.

By Leigh MacMillan
September 25, 2014

A path to sarcoidosis treatment

Vanderbilt investigators identify a new therapeutic target for the inflammatory lung disease sarcoidosis.

By VUMC News and Communications
September 18, 2014

State public health award named for Schaffner

The Tennessee Public Health Association and the Tennessee Medical Association are collaborating to establish the “William Schaffner, M.D., Public Health Hero Award,” to be presented annually to an individual who has demonstrated extraordinary efforts in the advancement of public health in Tennessee.
By Craig Boerner
August 13, 2014

High-dose flu vaccine more effective in elderly, Vanderbilt-led study shows

High-dose influenza vaccine is 24 percent more effective than the standard-dose vaccine in protecting persons ages 65 and over against influenza illness and its complications.
By Craig Boerner
May 1, 2014

Cutting-edge research to be showcased in May

By Bill Snyder
April 24, 2014

Schaffner honored by pharmacy association

William Schaffner, M.D., professor of Preventive Medicine at Vanderbilt University Medical Center, received the Immunization Champion Award — Friend of Pharmacy from the American Pharmacists Association (APA) at the group’s annual meeting recently in Orlando, Fla.
By Chanler Knowles
January 30, 2014

AIDS Clinical Trials Unit lands renewal of NIH funding

Vanderbilt University’s AIDS Clinical Trials Unit (ACTU) has received a seven-year grant renewal from the National Institutes of Health (NIH).
By Bill Snyder
January 23, 2014

Human and Helicobacter co-evolution

By VUMC News and Communications
January 15, 2014

HIV’s impact on B cells

Understanding how HIV infection affects immune system B cells may guide strategies for vaccine development.
By Leigh MacMillan
1 … 10 11 12 13 14